Skip to main content
Log in

Tissue Polypeptide Antigen and Carcinoembryonic Antigen Lack Diagnostic Accuracy in Urothelial Carcinoma

  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Carcinoembryonic antigen (CEA) and tissue polypeptide antigen (TPA) levels in serum and urine from 25 patients with bladder cancer and 42 patients with cancer of the renal pelvis/ureter have been evaluated as an aid for clinical diagnosis of urothelial cancer. The tumour CEA content varied markedly, from values obtained in normal urothelium up to 822 and 7306 ng/g wet tissue in cancer of the renal pelvis/ureter and bladder cancer, respectively. Serum and urine CEA levels were found not to correlate with the tumour CEA content. Serum CEA levels were found increased over 5 µg/L in up to 16% of bladder cancer patients, but only in 4.8% in renal pelvis/ureter cancer. Urine of cancer patients contained usually normal CEA levels. Increased serum TPA levels were found in 48% and 35.7% of patients with bladder cancer and cancer of renal pelvis/ureter, respectively. Urine TPA levels were significantly increased in both, patients with bladder cancer (p<0.001) and cancer of renal pelvis/ureter (p<0.01). The median values of urine TPA were 59, 1095 and 1325 U/L, in controls, patients with bladder cancer and cancer of renal pelvis/ureter, respectively. However, considering previously described increase of TPA in inflammatory diseases of urinary tract and in renal failure patients, results of urinary TPA obtained in the diagnostic workup of urothelial cancer should be cautiously interpreted. This study shows that serum and urine levels of CEA and TPA have no diagnostic accuracy required for clinical diagnosis of urothelial cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zimmerman, R., Wahren, B., Edsmyr, F.: Assessment of serial CEA determinations in urine of patients with bladder carcinoma. Cancer, 46, 1802 (1980).

    Google Scholar 

  2. Hall, R. R.: Carcinoembryonic antigen and urological carcinoma. A review after 7 years. Br. J. Urol., 52, 166 (1980).

    Google Scholar 

  3. Kumara, S., Costello, C. B., Glashan, R. W., Bjorklund, B.: The clinical significance of tissue polypeptide antigen (TPA) in the urine of bladder cancer patients. Br. J. Urol., 53, 578 (1981).

    Google Scholar 

  4. Stefanović, V., Ignjatović, M.: Tumor, serum and urine carcinoembryonic antigen (CEA) in upper urinary tract urothelial cancer. Nuc. Compact, 18, 230 (1987).

    Google Scholar 

  5. Rasmussen, H. H., Orntoft, T. F., Wolf, H., Celis, J. E.: Towards a comprehensive database of proteins from the urine of patients with bladder cancer. J. Urol., 155, 2113 (1996).

    Google Scholar 

  6. Maulard-Durdux, C., Toubert, M. E., Hennequin, C., Housset, M.: Serum tissue polypeptide antigen in bladder cancer as a tumor marker: a prospective study. J. Clin. Oncol., 15, 3446 (1977).

    Google Scholar 

  7. Vogel, J., Oehr, P., Maisey, R., Adolphs, H. D.: Comparison between tissue antigen analysis and plasma determinations for TPA and CEA in transitional cell carcinomas and in tumorfree urothelium of the urinary bladder. Cancer Detect. Prev., 11, 389 (1988).

    Google Scholar 

  8. Tizzani, A., Casetta, G., Cavallini, A., Piana, P., Piantino, P.: Blood and urine determinations of tissue polypeptide antigen in patients with bladder carcinoma. Minerva Urol. Nefrol., 42, 69 (1990).

    Google Scholar 

  9. Khoo, S. K., Warner, N. L., Lie, J. T., Mackay, I. R.: Carcinoembryonic antigenic activity of tissue extracts: a quantitative study of malignant and benign neoplasms, cirrhotic liver, normal adult and fetal organs. Int. J. Cancer, 11, 681 (1973).

    Google Scholar 

  10. Batata, M., Grabstald, H.: Upper urinary tract urothelial tumors. Urol. Clin. North Am., 3, 79 (1976).

    Google Scholar 

  11. Cukuranović, R., Ignjatović, M., Stefanović, V.: Urinary tract tumors and Balkan nephropathy in the South Morava River basin. Kidney Int., 40(Suppl. 34), 80 (1991).

    Google Scholar 

  12. Wahren, B., Edsmyr, F.: Carcinoembryonic antigen in serum, urine and cells of patients with bladder carcinoma. Urol. Res., 6, 221 (1978).

    Google Scholar 

  13. Van Poppel, H., Billen, J., Goethuys, H., Elgamal, A. A., Gerits, M., Mortelmans, L., Blanckaert, N., Baert, L.: Serum tissue polypeptide antigen (TPA) as tumor marker for bladder cancer. Anticancer Res., 16, 2205 (1996).

    Google Scholar 

  14. Carbin, B. E., Ekman, P., Eneroth, P., Nilsson, B.: Urine-TPA (tissue polypeptide antigen), flow cytometry and cytology as markers for tumor invasiveness in urinary bladder carcinoma. Urol. Res., 17, 269 (1989).

    Google Scholar 

  15. Pectasides, D., Bafaloucos, D., Antoniou, F., Gogou, L., Economides, N., Varthalitis, J., Dimitriades, M., Kosmidis, P., Athanassiou, A.: TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19–9 for monitoring transitional cell carcinoma of the bladder. Am. J. Clin. Oncol., 19, 271 (1996).

    Google Scholar 

  16. Filella, X., Menendez, V., Molina, R., Alcover, J., Carretero, P., Ballesta, A. M.: TPA prognostic value in superficial bladder cancer. Anticancer Res., 16, 2173 (1996).

    Google Scholar 

  17. Van der Gaast, A., Kirkels, W. J., Blijenberg, B. G., Splinter, T. A.: Evaluation of tissue polypeptide antigen serum levels for monitoring disease activity during chemotherapy in patients with transitional carcinoma of the urinary tract. J. Cancer Res. Clin. Oncol., 118, 626 (1992).

    Google Scholar 

  18. Stefanović, V., Ilić, S., Ignjatović, I., Cukuranović, R., Rajić, M., Mitić-Zlatković, M.: Elevated tumor markers in patients with Balkan endemic nephropathy. Int. Urol. Nephrol., 30, 621 (1998).

    Google Scholar 

  19. Putzki, H., Student, A., Breucker, K., Jablonski, M.: Reaction of the tumor markers CEA and TPA to a surgical trauma. J. Surg. Oncol., 33, 18 (1986).

    Google Scholar 

  20. Walz, G., Kunzendorf, U., Keller, F., Fitzner, R., Offermann, G.: Elevated tumor markers in hemodialysis patients. Am. J. Nephrol., 8, 187 (1988).

    Google Scholar 

  21. Cases, A., Filella, X., Molina, R., Ballesta, A. M., Lopez-Pedret, J., Revert, L.: Tumor markers in chronic renal failure and hemodialysis patients. Nephron, 55, 183 (1991).

    Google Scholar 

  22. Gajda, M., Tyloch, F., Jozwicki, W., Tyloch, J., Sujkowska, R., Skok, Z.: Diagnostic value of urine cytology and urine carcinoembryonic antigen (CEA) level in the distinction between bladder cancer and urinary tract infection. Int. J. Occup. Med. Environ. Health, 8, 103 (1995).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stefanović, V., Mitić-Zlatković, M., Ignjatović, I. et al. Tissue Polypeptide Antigen and Carcinoembryonic Antigen Lack Diagnostic Accuracy in Urothelial Carcinoma. Int Urol Nephrol 31, 443–449 (1999). https://doi.org/10.1023/A:1007103009313

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007103009313

Keywords

Navigation